1
|
Sobti RC, Singh N, Hussain S, Suri V,
Nijhawan R, Bharti AC, Bharadwaj M and Das BC: Aberrant promoter
methylation and loss of suppressor of cytokine signalling-1 gene
expression in the development of uterine cervical carcinogenesis.
Cell Oncol. 34:533–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chandra S, Barola N and Bahadur D:
Impedimetric biosensor for early detection of cervical cancer. Chem
Commun. 47:11258–11260. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
4
|
Qiang R, Wang F, Shi LY, Liu M, Chen S,
Wan HY, Li YX, Li X, Gao SY, Sun BC and Tang H: Plexin-B1 is a
target of miR-214 in cervical cancer and promotes the growth and
invasion of HeLa cells. Int J Biochem Cell Biol. 43:632–641. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Ng MR and Brugge JS: A stiff blow from the
stroma: collagen crosslinking drives tumor progression. Cancer
Cell. 16:455–457. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Trackman PC, Bedell-Hogan D, Tang J and
Kagan HM: Post-translational glycosylation and proteolytic
processing of a lysyl oxidase precursor. J Biol Chem.
267:8666–8671. 1992.PubMed/NCBI
|
7
|
Zhao Y, Chen L, Gao S, Toselli P, Stone P
and Li W: The critical role of the cellular thiol homeostasis in
cadmium perturbation of the lung extracellular matrix. Toxicology.
267:60–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Viguet-Carrin S, Garnero P and Delmas PD:
The role of collagen in bone strength. Osteoporos Int. 17:319–336.
2006. View Article : Google Scholar
|
9
|
Smith-Mungo LI and Kagan HM: Lysyl
oxidase: properties, regulation and multiple functions in biology.
Matrix Biol. 16:387–398. 1998. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kagan HM and Li W: Lysyl oxidase:
properties, specificity, and biological roles inside and outside of
the cell. J Cell Biochem. 88:660–672. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ferns GA, Lamb DJ and Taylor A: The
possible role of copper ions in atherogenesis: the Blue Janus.
Atherosclerosis. 133:139–152. 1997. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rodriguez C, Martinez-Gonzalez J, Raposo
B, Alcudia JF, Guadall A and Badimon L: Regulation of lysyl oxidase
in vascular cells: lysyl oxidase as a new player in cardiovascular
diseases. Cardiovasc Res. 79:7–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jeay S, Pianetti S, Kagan HM and
Sonenshein GE: Lysyl oxidase inhibits ras-mediated transformation
by preventing activation of NF-kappa B. Mol Cell Biol.
23:2251–2263. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Bouez C, Reynaud C, Noblesse E, Thepot A,
Gleyzal C, Kanitakis J, Perrier E, Damour O and Sommer P: The lysyl
oxidase LOX is absent in basal and squamous cell carcinomas and its
knockdown induces an invading phenotype in a skin equivalent model.
Clin Cancer Res. 12:1463–1469. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Min C, Kirsch KH, Zhao Y, Jeay S,
Palamakumbura AH, Trackman PC and Sonenshein GE: The tumor
suppressor activity of the lysyl oxidase propeptide reverses the
invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res.
67:1105–1112. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Erler JT, Bennewith KL, Cox TR, Lang G,
Bird D, Koong A, Le QT and Giaccia AJ: Hypoxia-induced lysyl
oxidase is a critical mediator of bone marrow cell recruitment to
form the premetastatic niche. Cancer Cell. 15:35–44. 2009.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Levental KR, Yu H, Kass L, Lakins JN,
Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W,
Yamauchi M, Gasser DL and Weaver VM: Matrix crosslinking forces
tumor progression by enhancing integrin signaling. Cell.
139:891–906. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Erler JT and Giaccia AJ: Lysyl oxidase
mediates hypoxic control of metastasis. Cancer Res. 66:10238–10241.
2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Erler JT, Bennewith KL, Nicolau M,
Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS and Giaccia AJ:
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature.
440:1222–1226. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Brown JM and Wilson WR: Exploiting tumour
hypoxia in cancer treatment. Nat Rev Cancer. 4:437–447. 2004.
View Article : Google Scholar
|
21
|
Vaupel P, Kelleher DK and Hockel M: Oxygen
status of malignant tumors: pathogenesis of hypoxia and
significance for tumor therapy. Semin Oncol. 28:29–35. 2001.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar
|
23
|
Sahlgren C, Gustafsson MV, Jin S,
Poellinger L and Lendahl U: Notch signaling mediates
hypoxia-induced tumor cell migration and invasion. Proc Natl Acad
Sci USA. 105:6392–6397. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
27
|
Erler JT, Cawthorne CJ, Williams KJ,
Koritzinsky M, Wouters BG, Wilson C, Miller C, Demonacos C,
Stratford IJ and Dive C: Hypoxia-mediated down-regulation of Bid
and Bax in tumors occurs via hypoxia-inducible factor 1-dependent
and -independent mechanisms and contributes to drug resistance. Mol
Cell Biol. 24:2875–2889. 2004. View Article : Google Scholar : PubMed/NCBI
|
28
|
Chen LJ, Zhao Y, Gao S, Chou IN, Toselli
P, Stone P and Li W: Downregulation of lysyl oxidase and
upregulation of cellular thiols in rat fetal lung fibroblasts
treated with cigarette smoke condensate. Toxicol Sci. 83:372–379.
2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chou DK, Zhao Y, Gao S, Chou IN, Toselli
P, Stone P and Li W: Perturbation of copper (Cu) homeostasis and
expression of Cu-binding proteins in cadmium-resistant lung
fibroblasts. Toxicol Sci. 99:267–276. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Palamakumbura AH and Trackman PC: A
fluorometric assay for detection of lysyl oxidase enzyme activity
in biological samples. Anal Biochem. 300:245–251. 2002. View Article : Google Scholar : PubMed/NCBI
|
31
|
Chen LJ, Li WD, Li SF, Su XW, Lin GY,
Huang YJ and Yan GM: Bleomycin induces upregulation of lysyl
oxidase in cultured human fetal lung fibroblasts. Acta Pharmacol
Sin. 31:554–559. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zhu W, Ou Y, Li Y, Xiao R, Shu M, Zhou Y,
Xie J, He S, Qiu P and Yan G: A small-molecule triptolide
suppresses angiogenesis and invasion of human anaplastic thyroid
carcinoma cells via down-regulation of the nuclear factor-kappa B
pathway. Mol Pharmacol. 75:812–819. 2009. View Article : Google Scholar
|
33
|
Hollosi P, Yakushiji JK, Fong KS, Csiszar
K and Fong SF: Lysyl oxidase-like 2 promotes migration in
noninvasive breast cancer cells but not in normal breast epithelial
cells. Int J Cancer. 125:318–327. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Erler JT and Weaver VM: Three-dimensional
context regulation of metastasis. Clin Exp Metastasis. 26:35–49.
2009. View Article : Google Scholar : PubMed/NCBI
|
35
|
Brahimi-Horn C, Mazure N and Pouyssegur J:
Signalling via the hypoxia-inducible factor-1alpha requires
multiple posttranslational modifications. Cell Signal. 17:1–9.
2005. View Article : Google Scholar
|
36
|
Wang V, Davis DA, Haque M, Huang LE and
Yarchoan R: Differential gene up-regulation by hypoxia-inducible
factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells.
Cancer Res. 65:3299–3306. 2005.PubMed/NCBI
|
37
|
Pez F, Dayan F, Durivault J, Kaniewski B,
Aimond G, Le Provost GS, Deux B, Clezardin P, Sommer P, Pouyssegur
J and Reynaud C: The HIF-1-inducible lysyl oxidase activates HIF-1
via the Akt pathway in a positive regulation loop and synergizes
with HIF-1 in promoting tumor cell growth. Cancer Res.
71:1647–1657. 2011. View Article : Google Scholar : PubMed/NCBI
|
38
|
Payne SL, Hendrix MJ and Kirschmann DA:
Paradoxical roles for lysyl oxidases in cancer - a prospect. J Cell
Biochem. 101:1338–1354. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Tepass U, Truong K, Godt D, Ikura M and
Peifer M: Cadherins in embryonic and neural morphogenesis. Nat Rev
Mol Cell Biol. 1:91–100. 2000. View Article : Google Scholar : PubMed/NCBI
|
41
|
Willis BC, Liebler JM, Luby-Phelps K,
Nicholson AG, Crandall ED, du Bois RM and Borok Z: Induction of
epithelial-mesenchymal transition in alveolar epithelial cells by
transforming growth factor-beta1: potential role in idiopathic
pulmonary fibrosis. Am J Pathol. 166:1321–1332. 2005. View Article : Google Scholar
|
42
|
Wu YY, Peck K, Chang YL, Pan SH, Cheng YF,
Lin JC, Yang RB, Hong TM and Yang PC: SCUBE3 is an endogenous
TGF-beta receptor ligand and regulates the epithelial-mesenchymal
transition in lung cancer. Oncogene. 30:3682–3693. 2011. View Article : Google Scholar : PubMed/NCBI
|
43
|
Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK,
Kim HK, Kim JS and Oh SC: Sonic hedgehog pathway promotes
metastasis and lymphangiogenesis via activation of Akt, EMT, and
MMP-9 pathway in gastric cancer. Cancer Res. 71:7061–7070. 2011.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Li W, Liu G, Chou IN and Kagan HM:
Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of
vascular smooth muscle cells. J Cell Biochem. 78:550–557. 2000.
View Article : Google Scholar : PubMed/NCBI
|